Literature DB >> 15753647

Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation.

Maria Antonietta Cerone1, Ryan J Ward, J Arturo Londoño-Vallejo, Chantal Autexier.   

Abstract

Dyskeratosis congenita (DC) is a rare multi-system syndrome characterized by nail dystrophy, abnormal skin pigmentation and mucosal leukoplakia. The gene mutated in the X-linked form of human DC encodes for dyskerin, a nucleolar pseudourydilase that is involved in rRNA maturation. Dyskerin is also involved in telomerase function through its interaction with the telomerase RNA (hTR). Mutations in dyskerin result in low levels of hTR, decreased telomerase activity and telomere shortening. Autosomal dominant DC is characterized by mutations in hTR, supporting the hypothesis that the DC phenotype may be caused by impaired telomere maintenance. Several mutations have been identified in different regions of hTR in patients affected by autosomal dominant DC. Recent reports have shown that coexpression of wild-type hTR with hTR harboring mutations found in the pseudoknot domain does not affect telomerase activity in vitro. However, these studies did not assess the consequences of mutant hTR expression at the telomeres. Here we provide the first direct in vivo evidence that a mutant hTR carrying the GC to AG double substitution in the pseudoknot at nucleotides 107-108 found in patients affected by autosomal dominant DC does not behave as a dominant-negative for telomere maintenance. Rather it reconstitutes a weakly active telomerase enzyme, which is defective in telomere elongation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753647

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

Review 1.  The biogenesis and regulation of telomerase holoenzymes.

Authors:  Kathleen Collins
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

Review 2.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 3.  How RNAi machinery enters the world of telomerase.

Authors:  Ilaria Laudadio; Claudia Carissimi; Valerio Fulci
Journal:  Cell Cycle       Date:  2019-05-07       Impact factor: 4.534

Review 4.  Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.

Authors:  Jixuan Gao; Hilda A Pickett
Journal:  Nat Rev Cancer       Date:  2022-07-05       Impact factor: 69.800

5.  Dyskerin is a component of the Arabidopsis telomerase RNP required for telomere maintenance.

Authors:  Kalpana Kannan; Andrew D L Nelson; Dorothy E Shippen
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

6.  Telomere dysfunction in human diseases: the long and short of it!

Authors:  Kathryn A Carroll; Hinh Ly
Journal:  Int J Clin Exp Pathol       Date:  2009-05-10

7.  Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita.

Authors:  Hua He; Yang Wang; Xiaolan Guo; Sonal Ramchandani; Jin Ma; Mei-Feng Shen; Dennis A Garcia; Yibin Deng; Asha S Multani; Mingjian James You; Sandy Chang
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

8.  Engineered telomere degradation models dyskeratosis congenita.

Authors:  Dirk Hockemeyer; Wilhelm Palm; Richard C Wang; Suzana S Couto; Titia de Lange
Journal:  Genes Dev       Date:  2008-06-11       Impact factor: 11.361

9.  TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase.

Authors:  Dong Yang; Quanyuan He; Hyeung Kim; Wenbin Ma; Zhou Songyang
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.486

10.  A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation.

Authors:  Delphine T Marie-Egyptienne; Maria Antonietta Cerone; J Arturo Londoño-Vallejo; Chantal Autexier
Journal:  Nucleic Acids Res       Date:  2005-09-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.